Cargando…

Functionality of Monoclonal Antibody Therapy in SARS-CoV-2

The coronavirus disease 2019 (COVID-19) pandemic emerged as a world crisis in 2019 and started a global search for optimal therapeutic regimen including vaccines, antiviral agents, and recently monoclonal antibody therapy. Clinical trials are currently underway for the efficacy of several neutralizi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ali, Ruhma, Patel, Aditya, Waqas, Muhammad A., Trivedi, Krunal, Slim, Jihad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451566/ https://www.ncbi.nlm.nih.gov/pubmed/36128060 http://dx.doi.org/10.14740/jmc3968

Ejemplares similares

A Case Series of SARS-CoV-2 and Influenza Co-infection
por: Ali, Ruhma, et al.
Publicado: (2021)

Roles and Interplay of SARS-CoV-2 Serology With Clinical Stages of Disease in COVID-19
por: Mutyala, Monica, et al.
Publicado: (2021)

Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases
por: Patel, Aditya, et al.
Publicado: (2021)

Late Evolution of Deep Neck Space Abscess: Was Intubation the Cause?
por: Ali, Ruhma, et al.
Publicado: (2022)

Severe Gastroparesis Flare: Is COVID-19 the Inciting Factor?
por: Patel, Aditya, et al.
Publicado: (2022)

455. Diagnostic Value of Hematological Parameters in Different Stages of the Disease in Covid-19 Patients
por: Ali, Ruhma, et al.
Publicado: (2021)

Monoclonal antibody therapies against SARS-CoV-2
por: Focosi, Daniele, et al.
Publicado: (2022)

Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia Secondary to Infected Seroma: A Rare Case Report
por: Ali, Ruhma, et al.
Publicado: (2022)

FLUID BALANCE AS AN INDEPENDENT PROGNOSTIC INDICATOR OF IN-HOSPITAL MORTALITY IN PATIENTS WITH HEART FAILURE AND COVID-19
por: PATEL, ADITYA, et al.
Publicado: (2022)

SARS-CoV-2 Monoclonal Antibodies in Children: Ethical Considerations
por: Wolfe, Ian D., et al.
Publicado: (2021)

Effect of monoclonal antibody therapy on the endogenous SARS-CoV-2 antibody response
por: Kim, Paul S., et al.
Publicado: (2022)

Monoclonal antibodies for COVID-19 therapy and SARS-CoV-2 detection
por: Hwang, Yu-Chyi, et al.
Publicado: (2022)

Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy
por: Ragonnet-Cronin, Manon, et al.
Publicado: (2023)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

SEVERE ALLERGIC ERYTHEMATOUS REACTION POSTMESSENGER RNA-BASED COVID-19 VACCINE
por: ALI, RUHMA, et al.
Publicado: (2022)

554. Clinical Impact of Monoclonal Antibody Therapy with SARS-CoV-2 Infection
por: Mann, Inderjit, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

When Influenza, Bacterial Pneumonia, and COVID-19 Co-exist
por: Owolabi, Modupeoluwa, et al.
Publicado: (2022)

Development of SARS-CoV-2 Nucleocapsid Specific Monoclonal Antibodies
por: Terry, James S., et al.
Publicado: (2020)

Development of Monoclonal Antibodies to Detect for SARS-CoV-2 Proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

Collection of Monoclonal Antibodies Targeting SARS-CoV-2 Proteins
por: Pribanić Matešić, Marina, et al.
Publicado: (2022)

Monoclonal antibodies binding data for SARS-CoV-2 proteins
por: Mishra, Nawneet, et al.
Publicado: (2022)

COMPARISON OF SOFA, QSOFA, AND MSOFA SCORES BASED ON SEROLOGY IN PATIENTS WITH COVID-19: A RETROSPECTIVE COHORT STUDY
por: PATEL, ADITYA, et al.
Publicado: (2021)

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2
por: Xie, Jiajia, et al.
Publicado: (2021)

Clinical application of SARS-CoV-2 antibody detection and monoclonal antibody therapies against COVID-19
por: Sun, Jin, et al.
Publicado: (2023)

Monoclonal antibodies for the S2 subunit of spike of SARS-CoV-1 cross-react with the newly-emerged SARS-CoV-2
por: Zheng, Zhiqiang, et al.
Publicado: (2020)

Phase 1 study of safety, pharmacokinetics, and antiviral activity of SARS‐CoV‐2 neutralizing monoclonal antibody ABBV‐47D11 in patients with COVID‐19
por: Shebley, Mohamad, et al.
Publicado: (2022)

Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2
por: Yu, Fei, et al.
Publicado: (2020)

A human monoclonal antibody blocking SARS-CoV-2 infection
por: Wang, Chunyan, et al.
Publicado: (2020)

Potent mouse monoclonal antibodies that block SARS-CoV-2 infection
por: Guo, Youjia, et al.
Publicado: (2021)

Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody
por: Terry, James S., et al.
Publicado: (2021)

Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)

Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies
por: Qiu, Hongyu, et al.
Publicado: (2021)

Current status of therapeutic monoclonal antibodies against SARS-CoV-2
por: Kumar, Sanjeev, et al.
Publicado: (2021)

Safety of Monoclonal Antibodies in Children Affected by SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

In-Silico Analysis of Monoclonal Antibodies against SARS-CoV-2 Omicron
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Total escape of SARS-CoV-2 from dual monoclonal antibody therapy in an immunocompromised patient
por: Jaki, Lena, et al.
Publicado: (2023)

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
por: Diamond, Michael, et al.
Publicado: (2021)

Identification of SARS-CoV RBD-targeting monoclonal antibodies with cross-reactive or neutralizing activity against SARS-CoV-2
por: Tai, Wanbo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ju5coh90lh2ddefcetjfah7am